- Home
- MPAA vs CVRX Comparison
MPAA vs CVRX Comparison
Compare MPAA & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPAA | CVRX |
|---|---|---|
| Founded | 1968 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.3M | 171.7M |
| IPO Year | 2007 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MPAA | CVRX |
|---|---|---|
| Price | $11.06 | $9.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $17.50 | $11.20 |
| AVG Volume (30 Days) | 107.0K | ★ 203.4K |
| Earning Date | 02-09-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.56 | 23.02 |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $757,354,000.00 | $56,651,000.00 |
| Revenue This Year | $1.50 | $16.65 |
| Revenue Next Year | $7.42 | $18.41 |
| P/E Ratio | $83.54 | ★ N/A |
| Revenue Growth | 5.53 | ★ 10.45 |
| 52 Week Low | $8.17 | $4.37 |
| 52 Week High | $18.12 | $13.15 |
Technical Indicators
Market Signals| Indicator | MPAA | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 65.61 |
| Support Level | $9.60 | $8.42 |
| Resistance Level | $12.57 | $10.39 |
| Average True Range (ATR) | 0.42 | 0.66 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 83.10 | 82.85 |
Price Performance
Historical ComparisonAbout MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.